Elite in Malaria

Bridget E. Barber

300 Herston Road, 
Brisbane, QLD, AU 
Elite in Malaria
300 Herston Road, 
Brisbane, QLD, AU 
OverviewLocationsClinical Research

Overview

Bridget Barber practices in Brisbane, Australia. Ms. Barber is rated as an Elite expert by MediFind in the treatment of Malaria. Her top areas of expertise are Malaria, Hemolysis, Sepsis, Alpha Thalassemia, and Splenectomy.

Her clinical research consists of co-authoring 114 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 105 articles and participated in 2 clinical trials in the study of Malaria.

Gender
Female

Locations

300 Herston Road, Brisbane, QLD 4006, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship of Pyronaridine in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium Falciparum.
A Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship of Pyronaridine in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium Falciparum.
Enrollment Status: Completed
Publish Date: April 16, 2025
Intervention Type: Biological, Drug
Study Phase: Phase 1
Artemether-lumefantrine vs Chloroquine in Patients With Acute Uncomplicated P. Knowlesi Malaria: a Randomized Open Label Trial in Sabah, Malaysia (CAN KNOW Trial)
Artemether-lumefantrine vs Chloroquine in Patients With Acute Uncomplicated P. Knowlesi Malaria: a Randomized Open Label Trial in Sabah, Malaysia (CAN KNOW Trial)
Enrollment Status: Completed
Publish Date: July 07, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

114 Total Publications

Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum.
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum.
Journal: Science translational medicine
Published: November 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Barber's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile